Journal
EXPERIMENTAL HEMATOLOGY
Volume 33, Issue 2, Pages 182-188Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2004.10.019
Keywords
-
Categories
Ask authors/readers for more resources
Objective. Various TEL-JAK2 fusions have been identified in patients with lymphoblastic and myeloid leukemias that result in constitutive activation of the JAK2 kinase domain. Such fusions can mediate factor-independent growth of hernatopoietic cell lines and induction of malignancy in mouse models. Materials and Methods. To assess whether zebrafish could be utilized as a suitable model for the study of myeloid oncogenesis, we generated a zebratish tel-jak2a fusion oncoprotein based on that seen in a case of chronic myeloid leukemia. This was transiently expressed in zebrafish embryos under the control of the spi1 promoter, which is strongly active in myeloid precursors. Results. Visual, histological, and molecular analysis revealed disruption of normal embryonic hematopoiesis, including perturbation of the myeloid and erythroid lineages. Conclusion. These results indicate that the zebrafish tel-jak2a oncoprotein is functional, and suggest that this organism will be useful for the experimental study of myeloid malignancy. (C) 2005 International Society for Experimental Hematology. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available